Psychopharmacology of Aggression in Schizophrenia
- 22 August 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 37 (5), 930-936
- https://doi.org/10.1093/schbul/sbr104
Abstract
The management of aggression in patients with schizophrenia is a complex and challenging clinical dilemma. It also is greatly influenced by prevailing societal and medicolegal considerations regarding the perceived associations between violence and mental illness. This article provides a succinct account of a complex area and offers evidence for available treatments to reduce the occurrence of violent behavior among patients with schizophrenia.Keywords
This publication has 39 references indexed in Scilit:
- Pathways to Aggression in Schizophrenia Affect Results of TreatmentSchizophrenia Bulletin, 2011
- Informed consent to research in persons with schizophrenia spectrum disordersNursing Ethics, 2010
- Comparison of Intramuscular Olanzapine, Orally Disintegrating Olanzapine Tablets, Oral Risperidone Solution, and Intramuscular Haloperidol in the Management of Acute Agitation in an Acute Care Psychiatric Ward in TaiwanJournal of Clinical Psychopharmacology, 2010
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary StatementsSchizophrenia Bulletin, 2009
- Olanzapine orally disintegrating tablets (Zyprexa ZydisR) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective studyThe World Journal of Biological Psychiatry, 2009
- Comparison of antipsychotic medication effects on reducing violence in people with schizophreniaThe British Journal of Psychiatry, 2008
- Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: Differences among three standards for the MacCAT-CR in patients with schizophreniaSchizophrenia Research, 2007
- Introduction: Methods, Commentary, and SummaryJournal of Psychiatric Practice, 2005
- Testing a Four-Factor Model of Psychopathy and Its Association With Ethnicity, Gender, Intelligence, and Violence.Journal of Consulting and Clinical Psychology, 2005
- Effectiveness of Rapid Initial Dose Escalation of up to Forty Milligrams per Day of Oral Olanzapine in Acute AgitationJournal of Clinical Psychopharmacology, 2003